MT1 vs MT2 Side Effects: What the Research Shows

MT1 (afamelanotide) and MT2 (melanotan II) cause the same general category of side effects, but MT2 tends to trigger them more often and more intensely. Nausea, flushing, appetite loss, and spontaneous erections are the reactions most frequently reported with MT2, while MT1 users more often describe milder nausea, headache, and implant-site discomfort. Neither peptide is FDA-approved for tanning in the United States.

Both are synthetic analogs of alpha-melanocyte-stimulating hormone (a-MSH). They darken skin by increasing melanin production, but they differ in potency, half-life, and how well the body tolerates them.

MT1 vs MT2 at a Glance

The two peptides are often discussed together, yet they behave very differently in the body.

• MT1 (afamelanotide): Longer-acting, usually delivered as a subcutaneous implant, slower tanning onset, generally milder systemic side effects.
• MT2 (melanotan II): Shorter-acting, injected more frequently, faster and darker tanning, higher rates of nausea, flushing, and sexual side effects.
• Regulatory status: Afamelanotide is approved as Scenesse for erythropoietic protoporphyria in the US and EU; melanotan II has no approved medical use anywhere.

Side Effects Compared: MT1 vs MT2

The table below summarizes how commonly each reaction is reported. Frequencies come from published afamelanotide trials and from user surveys for melanotan II, which has far less formal safety data.

Side effect	MT1 (afamelanotide)	MT2 (melanotan II)
Nausea	Common but usually mild	Very common, often dose-limiting
Flushing	Uncommon	Common, especially after injection
Appetite loss	Rare	Common
Spontaneous erections / libido changes	Rare	Common in men
Fatigue, yawning	Occasional	Common
Injection or implant site reaction	Implant site reactions reported	Injection site pain and irritation
Darkening of moles and nevi	Reported in clinical trials	Frequently reported
Typical dosing frequency	Implant every 2 months	Daily or every other day
Approved medical use	Yes, for EPP as Scenesse	None

MT2 Side Effects That Stand Out

Melanotan II is the peptide most often associated with dramatic side effects, largely because it is injected frequently and acts quickly.

• Nausea and vomiting: The most common complaint, sometimes severe enough to end use.
• Facial flushing: Often appears within minutes of injection and fades over an hour.
• Spontaneous erections: A distinctive MT2 effect in men, sometimes painful or prolonged.
• Appetite suppression: Reduced hunger is common and can lead to unintended weight loss.
• Fatigue and yawning: Frequently reported in the first hours after dosing.

Spontaneous erections and libido changes are the most distinctive MT2 effects. The prescription drug bremelanotide (Vyleesi) works through the same melanocortin receptors, and clinical reviews of vyleesi side effects list nausea, flushing, and headache as the most common complaints.

MT1 Side Effects: Milder but Not Risk-Free

Afamelanotide has been studied in controlled trials for erythropoietic protoporphyria, which gives it a more reliable safety picture. Reported reactions include nausea, headache, back pain, implant site reactions, and darkening of the skin and existing moles.

Because MT1 is released slowly from an implant, peak blood levels stay lower than with a bolus injection. That likely explains why flushing, spontaneous erections, and appetite loss appear far less often with MT1 than with MT2.

MT1 vs MT2 for Tanning: What the Trade-Off Looks Like

When people research mt1 vs mt2 for tanning, the decision usually comes down to speed versus tolerability.

• MT1: Slower onset over several weeks, longer-lasting color, fewer doses, milder nausea.
• MT2: Faster onset within days, darker color, more frequent injections, heavier side effect burden.

Neither peptide replaces sun protection, and neither prevents sunburn damage to the skin. A tan from melanotan does not make unprotected UV exposure safe.

Unregulated Supply and Hidden Risks

Melanotan products sold online are not pharmacy-grade. Independent testing has repeatedly found vials with incorrect peptide content, bacterial contamination, and far more active ingredient than the label states, which makes dosing unpredictable.

Appetite suppression from MT2 sometimes leads people to lump it in with weight-loss drugs. Anyone comparing those options should look at semaglutide vs tirzepatide side effects instead, because those are FDA-approved prescription medications with entirely different risk profiles.

People exploring other research peptides should apply the same caution: aod 9604 benefits and side effects and dsip side effects are still being characterized, and unregulated vials carry identical quality risks.

Safety Guidance and When to See a Doctor

Melanotan II is not FDA-approved for human use in the United States. Buying it online means using a substance with no required purity testing, no standard dosing, and no long-term safety data in healthy people.

Both peptides are generally discouraged for anyone with a personal or family history of melanoma, atypical moles, cardiovascular disease, or uncontrolled hypertension. Mood changes and anhedonia have been reported with MT2 as well.

New, darkening, or irregular moles should be evaluated by a dermatologist promptly. Anyone considering these peptides should talk with a healthcare professional first, especially if they take blood pressure medication or have any chronic condition.

The clearest takeaway: MT1 and MT2 are not interchangeable, and MT2 carries a noticeably higher side effect load. MT1's clinical data is stronger because it comes from approved medical use, while MT2 remains an unapproved compound with mostly anecdotal safety information.

COMMON QUESTIONS

Frequently Asked Questions

Is MT2 more dangerous than MT1?

MT2 is not approved for any medical use and is linked to higher rates of nausea, flushing, and spontaneous erections than MT1. Afamelanotide (MT1) is approved in the US and EU as Scenesse for erythropoietic protoporphyria, though it is not approved for tanning. Neither peptide has long-term safety data in healthy users.

What are the most common side effects of melanotan injections?

Nausea, flushing, appetite loss, and fatigue are the most frequently reported reactions, especially with MT2. Many users also notice darker moles, new freckles, and injection site irritation. Less common but more serious reports include blood pressure changes, severe nausea that forces a dose reduction, and mood changes.

Do MT1 and MT2 side effects go away with continued use?

Nausea and flushing often become less noticeable after the first few doses as the body adjusts. Other effects, such as appetite suppression, mole darkening, and libido changes, can persist with ongoing use. New or changing moles should be checked by a dermatologist rather than monitored at home.